UK Government to provide additional £160m to Cancer Drugs Fund
The UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients. The funding...
Venus signs agreement with Teva Canada to develop anti-cancer drug
India-based Venus Remedies has signed a collaborative agreement with Teva Canada for an anti-cancer drug, which is under patent protection until 2016. As part...
New Type 2 Diabetes Treatment Jardiance® (Empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies
New JARDIANCE Simple Savings program currently offered in doctors' offices and online
Jardiance® (empagliflozin) tablets are now available by prescription in pharmacies across the United...
Roche to acquire InterMune for $8.3bn
Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around $8.3bn. As part of the all-cash transaction, Roche has offered...
EISAI Files Lenvatinib in Europe for People With Radioiodine-Refractory Thyroid Cancer
FOR EU MEDIA ONLY: NOT FOR SWISS/U.S. MEDIA
EMA accepts accelerated review for orphan therapy in hard-to-treat thyroid cancer
Eisai announces today that it has filed...
Mesoblast and NIH partner on 120-patient trial to treat end-stage heart failure
Australia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung and Blood Institute to...
PTC’s Translarna receives conditional approval for nonsense mutation DMD in EU
The European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is a treatment for the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...